Preview
FILED: NEW YORK COUNTY CLERK 05/07/2024 04:55 PM INDEX NO. 805128/2019
NYSCEF DOC. NO. 312 RECEIVED NYSCEF: 05/07/2024
-REFERRED BY
'^PATIENT’S NAME
DATE:
CHIEF COMPLAINT:
PMH:
OB/GYN:. G: P: Ab: PJ^ MAMMOt
4>'t
V'' . '13
-Uk a ?)
MEDICATif N(S): 1 -H' ('i'J
ALLERGIES:
rosT^
FAMILY HX:
FATHER: 7 pA/
SIBLINGS: \
__________ n
SOCIAL HX: SMOKING:^ AJLS
ALCOHOI^^p.^
Exhibit T 00011
FILED: NEW YORK COUNTY CLERK 05/07/2024 04:55 PM INDEX NO. 805128/2019
NYSCEF DOC. NO. 312 RECEIVED NYSCEF: 05/07/2024
______(bi
PHYSICAL EXAM^
2m
HHIGHT "*0 WElGHr 21 np j TEMP^^
B/p hny/foD PULSE =â– - m . _ KESP_/5:_____________
POSmVE FINDINGS REQUIRE COMh^ENT
SKIN: â– NEG y/ POS []
»
HEBNT/NECK: NEG POS f]
LUNGS: NEG [].• POS [1
HEART; NEG^J,.]- POS []
BREASTS: NEG I ] .. POS [ ]
ABDOAmN: NEG [jx-' p^ n
BACK: .NEG y.- POS []
RECTAiTeXAM: NEG J]/ POS U
CL
ExrREimTiE& neg [^ pos []
AWSCULOSKELETAL: NEG POS []
PEMPOTKAL m ’H^POs" f]
VASCULAR;
NEUROLOGICAL: OTG [ f POS f]
ADDITIONAL COMMENTS:
LABS EKG
Exhibit T 00022
FILED: NEW YORK COUNTY CLERK 05/07/2024 04:55 PM INDEX NO. 805128/2019
NYSCEF DOC. NO. 312 RECEIVED NYSCEF: 05/07/2024
PREVENTIVE MEASURES
^WEIGHT LOSS
LOW FAT DIET
'^ERCiSE-
SUNSCREEN USE
'"skin check
STOP SMOKl NG __________________ ____________ ___
GUAIAC CARDS
FLEX SIGMOIDOSCOPY __
COLONOSCOPY _
ENDOSCOPY
BONE DENSRY STUDY
TSE
ABOVE DISCUSSED WITH PATIENT
OTOACOVSTIC EMISSION (OWE) TEST fSSXJlXS
Nffi:___________________ IM:
Eir; lin Result: PASS Ear: RIOfT Renlt; PASS
Test#'.W34« Tester: _ TesW; 10347 TiJtir!
Date: 04/02/14 IL-.SO'.Sl Date; D4/02/W ll’.flrig
Protocol: AJ PritDul: A]
Freq. ReniH DP OP-F Freq. Bl suit DP DP-NF
SOU PASS 2S SODO pAn 2fi
WBO PASS s 22 4060 PASS s IS
PASS la 30 3000 PASS 1 16
Exhibit T 00033
FILED: NEW YORK COUNTY CLERK 05/07/2024 04:55 PM INDEX NO. 805128/2019
NYSCEF DOC. NO. 312 RECEIVED NYSCEF: 05/07/2024
PATIENT SERVICE ORDER FORM
TODAVS DATE J‘7 / L < 1 DR. KRUMHOlZ DR. ROONFY
PATIENT DATE OF BIRTH ---
ADDRESS , SS# ,
INSURANCE :____________ -^-â– - - CO-PAY S ,
ORDERS FOR OUTSIDE SERVICES
UA SONOGRAM:
chest X-RAY
â–¡' uc . CrsCAN:____
STRESS TEST
D HEMOCULT BE 0 MRI:________
STOOLS MAMMOGRAM RULE OUT: _
BLOODS: ROUTINE AM YLASE LIPASE ESR CELIAC Ab
IBD MARKERS H. PYLORI HEP A,B,aCAbs.^^ CRP
TSH,T3,T4 IRON/TIBC FERRITIN LIVER PANEL
â– AMYLASE ISOENZYMES PSA PREGNANCY 612 FOIATE._
OTHER___________ :____________ _ _ ' '_____________________________ _______________
REFERRAUTO-SPEaAUSTS
ALLERGY;, _ . __________ _ Q CARDIOLOGY: __-------------------------- â–
0 ENOOCWNOLOGY-.---------- ---------- --------------------------------
0 DERMATOLOGY:
ENT: .______________ 0 sastroenterology:---------
n HEMATOLOGY; . _ a iNFECnO'35DS£ASE;J----------- ---------------------------------
NEPHROLOGY: NEUROLOGY:.,.-------- -------- ----------------—-------------------------
NUTRITION; :____________________ : 0 nB/GYN:_ —
D OPTHALMOLOGY: ' _____ Q ORTHOPEDIC:--------------------------------------- --.
n PULMONARY: __ ___ _____________ ____ ______________ _
PODIATRY:
PSYCHIATRY: ___________________ _ Q UROLOSY-.^^^------------------------------ --------- ---------—
PATIENT recall
Q COLON OFRCE HOSPITAL WHEN?
EGD OFFICE HOSPITAL WHEN? _
0 sig' OFFICE 0 HOSPITAL WHEN? „
CE WHEN? _
0 OV WHEN?
Exhibit T 00044
FILED: NEW YORK COUNTY CLERK 05/07/2024 04:55 PM INDEX NO. 805128/2019
NYSCEF DOC. NO. 312 RECEIVED NYSCEF: 05/07/2024
Date: fyij9|l£)
Ellen M. Rooney, MJ>.
Any changes since* the last ^dsit Change of address:
New Phone #: New Job#: , .
When was your last office visit? "
When was your last check up? _______________________________
What medications are you presently taking?
■—Pl Pr ■-.................... - ■■—----------------- —
Has there been a change in your medication since your W check-i^ or visit?
-.................. ...................................................... - ......................................... .....................
Have you had. any recent injury/surgery/illness since your last visit?
- - ... I ------------------ ------------------- — ■■-
Please list dates of last: .
Pap test: CQiAZfH _____________________________
Mammogram; \ Sonogram:
Bone Density Study:Eye Exam:
Flex sigmoidoscopy:Colonoscopy:
Skin Exam: _________________
Other:;.
Exhibit T 00055
FILED: NEW YORK COUNTY CLERK 05/07/2024 04:55 PM INDEX NO. 805128/2019
NYSCEF DOC. NO. 312 RECEIVED NYSCEF: 05/07/2024
04/02/2014 9;16r24
ID: «STflTM40402091624
Vent. Raje: 12 bpn
RR Interval: 824 ms
PR Interval: 136 ns
QRS Duration: 78 ms
QT Interval: 390 ms
QTc Interval: 411 ms
QT Dlspersiani 66 ms
P-R-T AXIS: 14* 85* 29*
Exhibit T 00066
FILED: NEW YORK COUNTY CLERK 05/07/2024 04:55 PM INDEX NO. 805128/2019
NYSCEF DOC. NO. 312 RECEIVED NYSCEF: 05/07/2024
Quest;
Oiagno.ik-
PATIENT XNPONMKTION REPORT STATUS
MATTHBWS, REGXWk
QDBST DIAGNOSTICS INCORFOfiATBD ORDBIUMO PHY8ICIAS
CLXBHT SBRVZCE 866.G97.837B DOB: 1972 AGE: 42
GENDER: F FASTING: Y
SBBCXHKM XBFORMATIOa CLIENT IHPORMRTIOH
SFBClKSNi AL124227 T676ai 10103225
REQXnsiTION: PHONE: 914.664.4842 ELLEN ROONEY, M.D.
Ill E. BOTH ST
NEW YORK, NY 10028
COLLECTED: 04/02/2014 NONE
RECEIVED: 04/03/2014 01:14
REPORTED: 04/09/2014 06:45
ist Name Xn Range Out of Range Re£er< Lab
cs1 PNL+HDL,TIBC W/FER RFX TBR
GLUCOSE,FASTING 76 65-99 mg/dL
SODIUM 138 135-146 mnol/L
POTASSIUM 4.1 3.5-5.3 mmol/L
CHLORIDE 103 98-110 mrnol/L
CARBON DIOXIDE 22 19-30 mmol/L
UREA NITROGEN 11 7-2S mg/dL
CREATININE 0.82 0.50-1.10 mg/dL
BUN/CREATININE RATIO NOTE 6-22
Bun/Creatinine ratio is not reported vdien the Bun and
Creatinine values are within normal limits.
URIC ACID 3.2 2.5-7.0 mg/dL
Therapeutic target for gout patients: <6.0 mg/dL
PHOSPHORUS 2.5- 4.5 mg/dL
CALCIUM L 5.6- 10.2 mg/dL
CHOLESTEROL,TOTAL T
1.27 125-200 mg/dL
HDL CHOLESTEROL \ 61 >=46 mg/dL
CHOLESTEROL/HDL RATIO iI 2.1 < = S.O
LDL CHOL, CALCULATED <130 mg/dL
See footnote 1
TRIGLYCERIDES I 60 <150 mg/dL
1
PROTEIN, TOTAL, SERUM 6.1-8.1 g/dL
'â– T72
ALBUMIN 3.6-5.1 g/dL
GLOBULIN,CALCULATED 3.3 1.9-3.7 g/dL
A/Q RATIO 1.3 1.0-2.5
BILIRUBIN,TOTAL 0.7 0.2-1.2 mg/dL
BILIRUBIN, DIRECT â– 0.2 < = 0.2 mg/dL
MjKALINE PHOSPHATASE'-*^
51 33-115 U/L
uTOWf/.v;
21 10-30 U/L
ALT 22 6-29 U/L
LD 149 100-200 U/L
TTBC 379 250-450 mcg/dL
TRANSFERRIN SATURATION 50 -50 *
EGFR NON AFR AMERICAN sa >-60 mL/min/1.73m2
EGFR AFRICAN AMERICAN 102 >=60 mL/min/1.73ra2
MATTHEWS, REGINA - AL124227 Page 1 - Continued on Page 2
Exhibit T 00077
FILED: NEW YORK COUNTY CLERK 05/07/2024 04:55 PM INDEX NO. 805128/2019
NYSCEF DOC. NO. 312 RECEIVED NYSCEF: 05/07/2024
4'*' 'l'
. V V i'^iagiiostics PATIBMT XMFORMXnOR SEPORT STATOS FINAL
. I*
MATTHEWS,REGINA
QOEST DZAOMOSnca ZBCORFORATED ORDBHINO PHySICIAN
IX)B: /1972 AGE: 42
GENDER: F FASTING; Y
BPECIMEV TNTORMATZOir CLIBHT ZMFORMATim
SF8CXME17: AL124227 T67681 10103225
COLLECTED: a4’/02/2014 NONE
REPORTED: 04/09/2014 , 06:45
2.
Test Name In Range d£ Range Reference Range Ziab
0.65 /
TSS 0.40-4.50 mlU/L TBR
T4,FREE 1.1 0.8-1.8 ng/dL TBR
FERRITIN 23 10-232 ng/mL TBR
CBC (INCLUDES DIFF/PLT) TBR
WBC 5.4 3.8-10.8 Thous/mcL
RfiC 4.36 3.80-5.10 Mill/mcL
HEMOGLOBIN ' 13.9 11.7-15.5 g/dL
HEMATOCRIT 42.1 35.0-45.0 *
MCV 96.6 80.0-100.0 £L
MCH 31.9 27.0-33.0 pg
MCHC 33.0 32.0-36.0 g/dL
RDW 14.6 11.0-15.0 *
PLATELET COUNT 226 140-400 Thous/mcL
MPV 9.1 7.5-11.5 £L
TOTAL NEUTROPHILS,* 56.0 38-80 *
TOTAL LYMPHOCYTES,* 34.5 15-49 *
MONOCYTES, * 8.6- 0-13 *
EOSINOPHILS,* 0.3 0-8 i
BASOPHILS,* 0.6 0-2 *
NEUTROPHILS,ABSOLUTE 3024 1500-7800 Cella/mcL
LYMPHOCYTES, ABSOLUTE 1863 850-3900 Cells/mcL
MONOCYTES, ABSOLUTE 464 200-950 Cells/mcL
EOSINOPHILS, ABSOLUTE 16 15-500 Cells/racL
BASOPHILS, ABSOLUTE 32 0-200 Cells/mcL
DIFFERENTIAL
An Instrument differential was performed.
MATTHEWS,REGINA - AL124227 Page 2 <â– Continued on Page 3
Exhibit T 00088
FILED: NEW YORK COUNTY CLERK 05/07/2024 04:55 PM INDEX NO. 805128/2019
NYSCEF DOC. NO. 312 RECEIVED NYSCEF: 05/07/2024
Quest
J/ l>iagnosiic'3
PATZBNI ZNFORNATZON XBPORT STAIDS FINAL
MATTHEWS, REGINA
QU88T DZAONOSTZCa ZNCORPORATBD OROBRZMQ myaiCXAM
DOB: 972 AGE: 42
GENDER: F FASTING: Y
SPECIMEN INFORMATZOK CLiem INFORMATICW
SPECZUEN: AL124227 T67681 10103225
COLLECTED: 04/02/2014 NONE
REPORTED: 04/09/2014 , 06:45
Test Name In Range Out of Range Reference Range Lab
URINALYSIS, COMPLETE TBR
COLOR Yellow Yellow
APPEARANCE Clear Clear
GLUCOSE,QL Negative Negative mg/dL
BILIRUBIN, URINE Negative Negative
KETONES Negative Negative mg/dL
SPECIFIC GRAVITY 1.025 1.001'1.035
BLOOD Negative Negative
PH 7.5 S.O-S.O
NITRITE Negative Negative
SQUAMOUS EPITHELIAL CELLS 0-5 or=6.5% Consistent with diabetes
This assay result is consistent with a decreased risk of
diabetes.
Currently, no consensus exists regarding use of hemoglobin,.j-^fL^JjQ
Ale for diagnosis of diabetes in c
QUESTASSURED 25-OH VIT. D TBR
16 ssi
VITAMIN D, 25-OH, D3 16 ng/mL
VITAMIN D, 25-OH, D2 <4 ng/mL
25-OHD3 indicates both endogenous ion and
supplementation. 25-OHD2 is an indicator of exogenous
sources such as diet or supplementation, Therapy is based on
measurement of Total 25-OHD, with levels <20 ng/mL indicative
of Vitamin D deficiency, vrtille levels between 20 ng/mL and
30 ng/mL suggest insufficiency. OptlToal levels are
> or = 30 ng/mL.
MATTHEWS,REGINA - AL124227 Page 4 - Continued on Page 5
10
Exhibit T 0010
FILED: NEW YORK COUNTY CLERK 05/07/2024 04:55 PM INDEX NO. 805128/2019
NYSCEF DOC. NO. 312 RECEIVED NYSCEF: 05/07/2024
. - \ Quest
z ■'■» PATimT ZMFOSMXTIOW REPORT STATUS FINAL
MATTHEWS,REGINA
Q0B6T DZACarOSTZCS ZHCORPORATBD DRDERZNG ParSZCIAM
DOB: /1972 AGE: 42
GENDER: F FASTING: Y
SPECIMBH ZHFORMILTIOH CbZBirT INTOBKATXCXI
BFBCIHBNi AL124227 T67681 10103225
COLLECTED: 04702/2014 NOME
REPORTED: 04/09/2014 , 06:45
Test Marne In Range Out of Raxzge Reference Razige Lab
ESTRADIOL, LC/MS/MS QNI
ESTRADIOL. LC/MS/MS 184 pg/mL
Adult Female Reference Ranges for Estradiol,
Ultrasensitive, LC/MS/MS:
Follicular Phase: 39-375 pg/mL
Luteal Phase: 4B-440 pg/mL
Postmenopausal Phase: < or = 10 pg/mL
Pediatric Female Reference Ranges for Estradiol.
Ultrasensitive, LC/MS/MS:
Pre-pubertal
{1-9 years): < or B 16 pg/mL
10-11 years: < or = 65 pg/mL
12-14 years: < or = 142 pg/mL
15-17 years: < or = 283 pg/mL
FOOTNOTE(S)i
1 Desirable range <100 mg/dL for patients with CHD or diabetes
and <70 mg/dL for diabetic patients with known heart
disease.
PERFORMIMG LABORATORY INFORMATION:
QNI Quest Diagnostics, Klchols Znstituta 3360B Ortega Highway San Juan Capistrano CA 92E75
liBboratory Director: Dr. Jon M. Rakannto CLIA No: 0500643352
TBR Quest Diagnostics one Malcoln Avsnus Teterboro NJ 07608 Laboratory Director: Janet Plscitelli, M.D.
CLZA NO: 3100696246
MATTHEWS, REGINA - AL124227 Page 5 - End of Repozrt
11
ini Exhibit T 0011
FILED: NEW YORK COUNTY CLERK 05/07/2024 04:55 PM INDEX NO. 805128/2019
NYSCEF DOC. NO. 312 RECEIVED NYSCEF: 05/07/2024
PATIENT: DATE: ----------- -—
REASON FOR VISIT;
RE: £
MEDICATIONS;
...............- -â–
RECOMMENDATIONS:
â– 6-at
REFERRALS; .. ;-
---------------------------------------------------- - , ■„ ,
'V'^l
DX
1.,2.I
3. 4.:
F/L
SIGNATURE:
12
Exhibit T 0012
FILED: NEW YORK COUNTY CLERK 05/07/2024 04:55 PM INDEX NO. 805128/2019
NYSCEF DOC. NO. 312 RECEIVED NYSCEF: 05/07/2024
PAtlEfJT SERVitE ORPfeR F&RM
TODAY'S DATE H/ | I *^1 DR, KRUMHOLZ . DR. ROONEY
PATIENT DATE OF BIRTH . . .
ADDRESS ___________________________ __________________ =____________ SS#„. ...
INSURANCE^ID# ________________ CO-PAY $
• ORDERS FOR OyTSIPE SERVICES
0 CHEST X-RAY UA SONOGRAM:______________________________________
D STRESS TEST UC CT SCAN:___________________________________ _
HEMOCULT D BE D MRI: - â– _______________________________
STOOLS D MAMMO(3fiSM RUtEaut: ... , â–
BLOODS: ROUTINE_____ AMYLASE LIPASE_____ ESR_____ CELIAC Ab___
IBP MARKERS___ __ H. PYLORl__^ HEPA,B,&CAbs_____ CRP
TSH,T3J4_____ IRON/TIBC_______ FERRITIN_____ LIVER PANEL,,____ •
AMYLASE ISOENZYM-ES- PSA_____ PREGNANCY_____ B12______ FOLATE .
OTHER ■- • . . • ................... . . : - ....................... .
REFERRALS TO SPECIALISTS
ALLERGY:U CARDIOLOGY: . .. .
D DERMATOLOGY: _______________ ENDOCRINOLOGY: . . • . .......
Q ENT;____________________ .______________ D GASTROENTEROLOGY: ,
Q HEMATOLOGY:. ... â– . - . INFECTIOUS DISEASE:
D NEPHROLOGY: . . . â– â– NEUROLOGY:.. .
0 NUTRITION: ;__________________________ 0 - .... .. .
0 OPTHALMOLOGY: '. -_______________________ L-.
ORtHUl^BblC; - â– ., -....-
PODIATRY: . ■■• ■. . . iJPUtNiSNARV:. ______ ____ -.... . . -
D PSYCHIATRY: _______________ ____________ tiUHology:, .... . â– â– â– â– â– .-
PATIENT RECALL
0 COLON OFFICE 0 HOSPITAL WHEN?
0 E6D OFFICE HOSPITAL WHEN?
SIG OFFICE HOSPITAL when?
Q CE WHEN?______
Q OV WHEN? .
13
Exhibit T 0013
FILED: NEW YORK COUNTY CLERK 05/07/2024 04:55 PM INDEX NO. 805128/2019
NYSCEF DOC. NO. 312 RECEIVED NYSCEF: 05/07/2024
Quest
Diagnostics XBPOBT STATUS FINAL
PATIENT INFORMATION
MATTHEWS , REGINA
QUBST DIAONOaTICS INCORPOllATBb ORDBAENO PHYSICIAN
CLZEWT 3B11VZC8 B66.6S7.B37B DOB: /1972 AGE: 42
GENDER; F
SPGCZKBB INPOBMMIQII CLZetTT UfFOBMATZCBI
SSSCIMZN: A2r216577 T67681 10103225
REQUISITION: PHONE: ELLEN ROONEY, M.D.
I-II e. both st
NEW YORE, NY 1D02B
COLLECTED: 04/16/2014 NONE
RECEIVED: 04/17/2014 03:59
REPORTED: 04/22/2014 06:45
Test Nane In Range Out of Range Reference Range Lab
LIVER PANEL II TBR
PROTEIN, TOTAL, SERUM 7.4 6.1-B.l g/dL
ALBUMIN 4.2 3.6-5.1 g/dL
GLOBULIN, CALCULATED 3.2 1.9-3.7 g/dL
BILIRUBIN, TOTAL 0.3 0.2-1.2 rog/dL
BILIRUBIN, DIRECT < = 0.2 Tng/dL
ALKALINE PHOSPHATASE 33-115 U/L
AST 10-30 O/L
ALT 6-29 U/L
LD 100-200 U/L
HEREDITARY HEMOCHROMAT,NY AMD
DNA MUTATION ANALYSIS
DNA MUTATION ANALYSIS
RESUL-^^NEGATIVE
INTERPRE^STIC®7^m^ testing indicates that this 41^14
individual is negative for the C2B2Y and H63D mutations
in the HFE gene. This negative result significantly â– pt OjuJU/MJi-te
reduces the likelihood of hereditary hemochromatosiB
(HH) in this individual. However, it does not rule out
the presence of other mutations within the HFE gene or
a diagnosis of HH. The risk of this individual
carrying a HFE mutation other than those tested in this
assay depends greatly on family and clinical history as
well as ethnicity. This assay does not test for other
primary or secondary iron overload disorders.
Kasina than Mural idharan, Ph. D.,
Director, Molecular Genetics
Hereditary hemochromatosis (HH) is an autosomal
recessive disorder of iron metabolism that results in
iron overload and potential organ failure. It is one
of the most comnon genetic disorders in individuals of
European-Caucasian ancestry, with an estimated carrier
frequency of 10%r. HH is caused by mutations in the HFE
MATTHEWS,REGINA - AN216577 Page 1 - Continued on Page 2
14
ft ci ••*** *1 r W* *r >*♦••**• •av* ** IMMN*W** •v ***«
Exhibit T 0014
FILED: NEW YORK COUNTY CLERK 05/07/2024 04:55 PM INDEX NO. 805128/2019
NYSCEF DOC. NO. 312 RECEIVED NYSCEF: 05/07/2024
PATIENT INFORMATION EEFORT STATOe FINAL
- MATTHEWS, REGINA
Q065T DZAONOSnCS IWCORPORATZD ORDERING PHYSICIAN
DOB: /1972 AGE: 42
GENDER: F
SPECIMEN INPOBMATiaN CLIENT INFORMATION
SPECZMENt AN216577 T676B1 10103225
COLLECTED: 04'/16/2014 NOME
REPOETEDi 04/22/2014 , 06:45
Teat Maz&e Zn Range Out o£ Range Reference Range Lab
gene. Moat individuals with HH (60-*90%) are homozygous
for the C2B2y mutation. A smaller percentage o£
affected individuals are either compound heterozygous
for the C2B2Y and H63D mutations (3%~B*} , or homozygous
for the H63D mutation (approximately 1%) .
This assay detects the two mutations in the HFE gene,
C282Y (MM_000410.2: c.B45G>A) and H63D (NM_000410.2: c.
187C>G), that are conROonly associated with HH. The
mutations are detected by multiplex-polymerase chain
reaction (PCR) amplification, followed by digestion of
the an^lification products with the restriction enzymes
Raal and NlalXI, for the detection of the C2B2Y and
K63D mutations respectively. Fluorescent-labeled
restriction fragments are detected by capillary
electrophoresis.
Thia assay does not detect other mutations in the HFE
gene that can cause UH. since genetic variation and
other factors can affect the accuracy of direct
mutation testing, these results should be interpreted
in light of clinical and familial data.
For assistance with interpretation of these results,
please contact your local Quest Diagnostics genetic
counselor or call 1-B66-GENEINFO (436-3463).
This test was developed and its performance
characteristics have been determined by Quest
Diagnostics Nichols Institute, Chantilly, VA.
Performance characteristics refer to the
analytical performance of the test.
For more information on this test, go to
http: //education. questdiagnostics. ccNn/faq/hemochromatos
MATTHEWS,REGINA - AN216577 Page 2 - Continued on Page 3
15
Exhibit T 0015
FILED: NEW YORK COUNTY CLERK 05/07/2024 04:55 PM INDEX NO. 805128/2019
NYSCEF DOC. NO. 312 RECEIVED NYSCEF: 05/07/2024
Quest
Diagnostics RBPOKT STATUS FINAL
PXrXBNT INFORMATION
MATTHEWS,REGINA
QUEST DIAGNOSTICS IHCORPOHATBD ORDENlira mYSXCZAH
DOB: /1972 AGE; 42
GENDER: F
BKCIMBN ZNFORMATI(» CIjIEin ZNFORKATKNI
SPECIMEN: AN216577 T67681 10103225
COLLECTED: 04716/2014 . NONE
REPORTED: 04/22/2014 , 06:45
PERFORMING LABORATORY INFORMATION:
AMD Quest Oiagnostics Nichols Chantilly 14225 Nevrtnrook Drive Chantilly VA 20151
Laboratory Directan Kenneth Sisco, MD,PhD CLIA No: 49DD221801
TBR Quest Diagnostics One Malcolm Avenue Teterboro NU 07608 Laboratory Director: Janet Piecitelll, H.D.
CLZA No: 3100696246
MATTHEWS,REGINA - AN216S77 Page 3 - End of Report
16
Exhibit T 0016
FILED: NEW YORK COUNTY CLERK 05/07/2024 04:55 PM INDEX NO. 805128/2019
NYSCEF DOC. NO. 312 RECEIVED NYSCEF: 05/07/2024
CHP 5/24/2014 11:46:40 AM PAGE 2/003 Fax Server
WEST SIDE RADlOinGY
ASSOCIATES. EC.
■425 West 59th Street ♦ NEW YORK, NY 10019 ♦ Phone: (212) 523-7533 Fax: (212) 523-7318
Patient Name: MATTHEWS, REGINA
ELLEN ROONEY, MD Patient Number: 10'iOOQi0^886
INTERNAL MEDICINE Date of Birth: 197?“^
111 BAST80THST Req Provider: ROONEY, ELLEN, MD
NEW YORK, NY 1002 L Att Provider: ROONEY, ELLEN
Primary Study: 8355113 (5/24/14) - (WS) US UPPER ABDOMEN COMPLETE
_______________________________________ FINAL REPORT___________
Dear Dr. Rooney:
ULTRASOUND EXAMINATION OF THE ABDOMEN
HISTOrI: Elevated LFTs
FINDINGS: Ultrasound examination of the abdomen was performed.
The right kidney measures approximately 10.6 cm long and the left approximately 11.1 cm long. Both kidneys
demonstrate grossly normal cortical echogenicity with no evidence of hydronephrosis. The renal cortical
thickness qipears well nmintained. There b no perinephric fluid collection or gross evidence of large shadowing
renal stone.
The liver aj^ears ncxmal in size with nonnal overall echotexture. No gross large hepatic mass is identified. There
is no ascites. There is no morphologic evidmce of advanced cirrhosis. No significant intrahepatic txle duct
dilatation is identified. The common duct measures approximately 2 mm, within normal limits. The spleen
measures approximately 8.8 cm. There is no evidence of gallstones. No sonographic evidence of cholecystitis is
noted. The partially visualized pancreas and aorta/TVC a
Preview
FILED: NEW YORK COUNTY CLERK 05/07/2024 04:55 PM INDEX NO. 805128/2019 NYSCEF DOC. NO. 312 RECEIVED NYSCEF: 05/07/2024 -REFERRED BY '^PATIENT’S NAME DATE: CHIEF COMPLAINT: PMH: OB/GYN:. G: P: Ab: PJ^ MAMMOt 4>'t V'' . '13 -Uk a ?) MEDICATif N(S): 1 -H' ('i'J ALLERGIES: rosT^ FAMILY HX: FATHER: 7 pA/ SIBLINGS: \ __________ n SOCIAL HX: SMOKING:^ AJLS ALCOHOI^^p.^ Exhibit T 00011 FILED: NEW YORK COUNTY CLERK 05/07/2024 04:55 PM INDEX NO. 805128/2019 NYSCEF DOC. NO. 312 RECEIVED NYSCEF: 05/07/2024 ______(bi PHYSICAL EXAM^ 2m HHIGHT "*0 WElGHr 21 np j TEMP^^ B/p hny/foD PULSE =■- m . _ KESP_/5:_____________ POSmVE FINDINGS REQUIRE COMh^ENT SKIN: ■NEG y/ POS [] » HEBNT/NECK: NEG POS f] LUNGS: NEG [].• POS [1 HEART; NEG^J,.]- POS [] BREASTS: NEG I ] .. POS [ ] ABDOAmN: NEG [jx-' p^ n BACK: .NEG y.- POS [] RECTAiTeXAM: NEG J]/ POS U CL ExrREimTiE& neg [^ pos [] AWSCULOSKELETAL: NEG POS [] PEMPOTKAL m ’H^POs" f] VASCULAR; NEUROLOGICAL: OTG [ f POS f] ADDITIONAL COMMENTS: LABS EKG Exhibit T 00022 FILED: NEW YORK COUNTY CLERK 05/07/2024 04:55 PM INDEX NO. 805128/2019 NYSCEF DOC. NO. 312 RECEIVED NYSCEF: 05/07/2024 PREVENTIVE MEASURES ^WEIGHT LOSS LOW FAT DIET '^ERCiSE- SUNSCREEN USE '"skin check STOP SMOKl NG __________________ ____________ ___ GUAIAC CARDS FLEX SIGMOIDOSCOPY __ COLONOSCOPY _ ENDOSCOPY BONE DENSRY STUDY TSE ABOVE DISCUSSED WITH PATIENT OTOACOVSTIC EMISSION (OWE) TEST fSSXJlXS Nffi:___________________ IM: Eir; lin Result: PASS Ear: RIOfT Renlt; PASS Test#'.W34« Tester: _ TesW; 10347 TiJtir! Date: 04/02/14 IL-.SO'.Sl Date; D4/02/W ll’.flrig Protocol: AJ PritDul: A] Freq. ReniH DP OP-F Freq. Bl suit DP DP-NF SOU PASS 2S SODO pAn 2fi WBO PASS s 22 4060 PASS s IS PASS la 30 3000 PASS 1 16 Exhibit T 00033 FILED: NEW YORK COUNTY CLERK 05/07/2024 04:55 PM INDEX NO. 805128/2019 NYSCEF DOC. NO. 312 RECEIVED NYSCEF: 05/07/2024 PATIENT SERVICE ORDER FORM TODAVS DATE J‘7 / L < 1 DR. KRUMHOlZ DR. ROONFY PATIENT DATE OF BIRTH --- ADDRESS , SS# , INSURANCE :____________ -^-■- - CO-PAY S , ORDERS FOR OUTSIDE SERVICES UA SONOGRAM: chest X-RAY □' uc . CrsCAN:____ STRESS TEST D HEMOCULT BE 0 MRI:________ STOOLS MAMMOGRAM RULE OUT: _ BLOODS: ROUTINE AM YLASE LIPASE ESR CELIAC Ab IBD MARKERS H. PYLORI HEP A,B,aCAbs.^^ CRP TSH,T3,T4 IRON/TIBC FERRITIN LIVER PANEL ■AMYLASE ISOENZYMES PSA PREGNANCY 612 FOIATE._ OTHER___________ :____________ _ _ ' '_____________________________ _______________ REFERRAUTO-SPEaAUSTS ALLERGY;, _ . __________ _ Q CARDIOLOGY: __-------------------------- ■0 ENOOCWNOLOGY-.---------- ---------- -------------------------------- 0 DERMATOLOGY: ENT: .______________ 0 sastroenterology:--------- n HEMATOLOGY; . _ a iNFECnO'35DS£ASE;J----------- --------------------------------- NEPHROLOGY: NEUROLOGY:.,.-------- -------- ----------------—------------------------- NUTRITION; :____________________ : 0 nB/GYN:_ — D OPTHALMOLOGY: ' _____ Q ORTHOPEDIC:--------------------------------------- --. n PULMONARY: __ ___ _____________ ____ ______________ _ PODIATRY: PSYCHIATRY: ___________________ _ Q UROLOSY-.^^^------------------------------ --------- ---------— PATIENT recall Q COLON OFRCE HOSPITAL WHEN? EGD OFFICE HOSPITAL WHEN? _ 0 sig' OFFICE 0 HOSPITAL WHEN? „ CE WHEN? _ 0 OV WHEN? Exhibit T 00044 FILED: NEW YORK COUNTY CLERK 05/07/2024 04:55 PM INDEX NO. 805128/2019 NYSCEF DOC. NO. 312 RECEIVED NYSCEF: 05/07/2024 Date: fyij9|l£) Ellen M. Rooney, MJ>. Any changes since* the last ^dsit Change of address: New Phone #: New Job#: , . When was your last office visit? " When was your last check up? _______________________________ What medications are you presently taking? ■—Pl Pr ■-.................... - ■■—----------------- — Has there been a change in your medication since your W check-i^ or visit? -.................. ...................................................... - ......................................... ..................... Have you had. any recent injury/surgery/illness since your last visit? - - ... I ------------------ ------------------- — ■■- Please list dates of last: . Pap test: CQiAZfH _____________________________ Mammogram; \ Sonogram: Bone Density Study:Eye Exam: Flex sigmoidoscopy:Colonoscopy: Skin Exam: _________________ Other:;. Exhibit T 00055 FILED: NEW YORK COUNTY CLERK 05/07/2024 04:55 PM INDEX NO. 805128/2019 NYSCEF DOC. NO. 312 RECEIVED NYSCEF: 05/07/2024 04/02/2014 9;16r24 ID: «STflTM40402091624 Vent. Raje: 12 bpn RR Interval: 824 ms PR Interval: 136 ns QRS Duration: 78 ms QT Interval: 390 ms QTc Interval: 411 ms QT Dlspersiani 66 ms P-R-T AXIS: 14* 85* 29* Exhibit T 00066 FILED: NEW YORK COUNTY CLERK 05/07/2024 04:55 PM INDEX NO. 805128/2019 NYSCEF DOC. NO. 312 RECEIVED NYSCEF: 05/07/2024 Quest; Oiagno.ik- PATIENT XNPONMKTION REPORT STATUS MATTHBWS, REGXWk QDBST DIAGNOSTICS INCORFOfiATBD ORDBIUMO PHY8ICIAS CLXBHT SBRVZCE 866.G97.837B DOB: 1972 AGE: 42 GENDER: F FASTING: Y SBBCXHKM XBFORMATIOa CLIENT IHPORMRTIOH SFBClKSNi AL124227 T676ai 10103225 REQXnsiTION: PHONE: 914.664.4842 ELLEN ROONEY, M.D. Ill E. BOTH ST NEW YORK, NY 10028 COLLECTED: 04/02/2014 NONE RECEIVED: 04/03/2014 01:14 REPORTED: 04/09/2014 06:45 ist Name Xn Range Out of Range Re£er< Lab cs1 PNL+HDL,TIBC W/FER RFX TBR GLUCOSE,FASTING 76 65-99 mg/dL SODIUM 138 135-146 mnol/L POTASSIUM 4.1 3.5-5.3 mmol/L CHLORIDE 103 98-110 mrnol/L CARBON DIOXIDE 22 19-30 mmol/L UREA NITROGEN 11 7-2S mg/dL CREATININE 0.82 0.50-1.10 mg/dL BUN/CREATININE RATIO NOTE 6-22 Bun/Creatinine ratio is not reported vdien the Bun and Creatinine values are within normal limits. URIC ACID 3.2 2.5-7.0 mg/dL Therapeutic target for gout patients: <6.0 mg/dL PHOSPHORUS 2.5- 4.5 mg/dL CALCIUM L 5.6- 10.2 mg/dL CHOLESTEROL,TOTAL T 1.27 125-200 mg/dL HDL CHOLESTEROL \ 61 >=46 mg/dL CHOLESTEROL/HDL RATIO iI 2.1 < = S.O LDL CHOL, CALCULATED <130 mg/dL See footnote 1 TRIGLYCERIDES I 60 <150 mg/dL 1 PROTEIN, TOTAL, SERUM 6.1-8.1 g/dL '■T72 ALBUMIN 3.6-5.1 g/dL GLOBULIN,CALCULATED 3.3 1.9-3.7 g/dL A/Q RATIO 1.3 1.0-2.5 BILIRUBIN,TOTAL 0.7 0.2-1.2 mg/dL BILIRUBIN, DIRECT ■0.2 < = 0.2 mg/dL MjKALINE PHOSPHATASE'-*^ 51 33-115 U/L uTOWf/.v; 21 10-30 U/L ALT 22 6-29 U/L LD 149 100-200 U/L TTBC 379 250-450 mcg/dL TRANSFERRIN SATURATION 50 -50 * EGFR NON AFR AMERICAN sa >-60 mL/min/1.73m2 EGFR AFRICAN AMERICAN 102 >=60 mL/min/1.73ra2 MATTHEWS, REGINA - AL124227 Page 1 - Continued on Page 2 Exhibit T 00077 FILED: NEW YORK COUNTY CLERK 05/07/2024 04:55 PM INDEX NO. 805128/2019 NYSCEF DOC. NO. 312 RECEIVED NYSCEF: 05/07/2024 4'*' 'l' . V V i'^iagiiostics PATIBMT XMFORMXnOR SEPORT STATOS FINAL . I* MATTHEWS,REGINA QOEST DZAOMOSnca ZBCORFORATED ORDBHINO PHySICIAN IX)B: /1972 AGE: 42 GENDER: F FASTING; Y BPECIMEV TNTORMATZOir CLIBHT ZMFORMATim SF8CXME17: AL124227 T67681 10103225 COLLECTED: a4’/02/2014 NONE REPORTED: 04/09/2014 , 06:45 2. Test Name In Range d£ Range Reference Range Ziab 0.65 / TSS 0.40-4.50 mlU/L TBR T4,FREE 1.1 0.8-1.8 ng/dL TBR FERRITIN 23 10-232 ng/mL TBR CBC (INCLUDES DIFF/PLT) TBR WBC 5.4 3.8-10.8 Thous/mcL RfiC 4.36 3.80-5.10 Mill/mcL HEMOGLOBIN ' 13.9 11.7-15.5 g/dL HEMATOCRIT 42.1 35.0-45.0 * MCV 96.6 80.0-100.0 £L MCH 31.9 27.0-33.0 pg MCHC 33.0 32.0-36.0 g/dL RDW 14.6 11.0-15.0 * PLATELET COUNT 226 140-400 Thous/mcL MPV 9.1 7.5-11.5 £L TOTAL NEUTROPHILS,* 56.0 38-80 * TOTAL LYMPHOCYTES,* 34.5 15-49 * MONOCYTES, * 8.6- 0-13 * EOSINOPHILS,* 0.3 0-8 i BASOPHILS,* 0.6 0-2 * NEUTROPHILS,ABSOLUTE 3024 1500-7800 Cella/mcL LYMPHOCYTES, ABSOLUTE 1863 850-3900 Cells/mcL MONOCYTES, ABSOLUTE 464 200-950 Cells/mcL EOSINOPHILS, ABSOLUTE 16 15-500 Cells/racL BASOPHILS, ABSOLUTE 32 0-200 Cells/mcL DIFFERENTIAL An Instrument differential was performed. MATTHEWS,REGINA - AL124227 Page 2 <■Continued on Page 3 Exhibit T 00088 FILED: NEW YORK COUNTY CLERK 05/07/2024 04:55 PM INDEX NO. 805128/2019 NYSCEF DOC. NO. 312 RECEIVED NYSCEF: 05/07/2024 Quest J/ l>iagnosiic'3 PATZBNI ZNFORNATZON XBPORT STAIDS FINAL MATTHEWS, REGINA QU88T DZAONOSTZCa ZNCORPORATBD OROBRZMQ myaiCXAM DOB: 972 AGE: 42 GENDER: F FASTING: Y SPECIMEN INFORMATZOK CLiem INFORMATICW SPECZUEN: AL124227 T67681 10103225 COLLECTED: 04/02/2014 NONE REPORTED: 04/09/2014 , 06:45 Test Name In Range Out of Range Reference Range Lab URINALYSIS, COMPLETE TBR COLOR Yellow Yellow APPEARANCE Clear Clear GLUCOSE,QL Negative Negative mg/dL BILIRUBIN, URINE Negative Negative KETONES Negative Negative mg/dL SPECIFIC GRAVITY 1.025 1.001'1.035 BLOOD Negative Negative PH 7.5 S.O-S.O NITRITE Negative Negative SQUAMOUS EPITHELIAL CELLS 0-5 or=6.5% Consistent with diabetes This assay result is consistent with a decreased risk of diabetes. Currently, no consensus exists regarding use of hemoglobin,.j-^fL^JjQ Ale for diagnosis of diabetes in c QUESTASSURED 25-OH VIT. D TBR 16 ssi VITAMIN D, 25-OH, D3 16 ng/mL VITAMIN D, 25-OH, D2 <4 ng/mL 25-OHD3 indicates both endogenous ion and supplementation. 25-OHD2 is an indicator of exogenous sources such as diet or supplementation, Therapy is based on measurement of Total 25-OHD, with levels <20 ng/mL indicative of Vitamin D deficiency, vrtille levels between 20 ng/mL and 30 ng/mL suggest insufficiency. OptlToal levels are > or = 30 ng/mL. MATTHEWS,REGINA - AL124227 Page 4 - Continued on Page 5 10 Exhibit T 0010 FILED: NEW YORK COUNTY CLERK 05/07/2024 04:55 PM INDEX NO. 805128/2019 NYSCEF DOC. NO. 312 RECEIVED NYSCEF: 05/07/2024 . - \ Quest z ■'■» PATimT ZMFOSMXTIOW REPORT STATUS FINAL MATTHEWS,REGINA Q0B6T DZACarOSTZCS ZHCORPORATBD DRDERZNG ParSZCIAM DOB: /1972 AGE: 42 GENDER: F FASTING: Y SPECIMBH ZHFORMILTIOH CbZBirT INTOBKATXCXI BFBCIHBNi AL124227 T67681 10103225 COLLECTED: 04702/2014 NOME REPORTED: 04/09/2014 , 06:45 Test Marne In Range Out of Raxzge Reference Razige Lab ESTRADIOL, LC/MS/MS QNI ESTRADIOL. LC/MS/MS 184 pg/mL Adult Female Reference Ranges for Estradiol, Ultrasensitive, LC/MS/MS: Follicular Phase: 39-375 pg/mL Luteal Phase: 4B-440 pg/mL Postmenopausal Phase: < or = 10 pg/mL Pediatric Female Reference Ranges for Estradiol. Ultrasensitive, LC/MS/MS: Pre-pubertal {1-9 years): < or B 16 pg/mL 10-11 years: < or = 65 pg/mL 12-14 years: < or = 142 pg/mL 15-17 years: < or = 283 pg/mL FOOTNOTE(S)i 1 Desirable range <100 mg/dL for patients with CHD or diabetes and <70 mg/dL for diabetic patients with known heart disease. PERFORMIMG LABORATORY INFORMATION: QNI Quest Diagnostics, Klchols Znstituta 3360B Ortega Highway San Juan Capistrano CA 92E75 liBboratory Director: Dr. Jon M. Rakannto CLIA No: 0500643352 TBR Quest Diagnostics one Malcoln Avsnus Teterboro NJ 07608 Laboratory Director: Janet Plscitelli, M.D. CLZA NO: 3100696246 MATTHEWS, REGINA - AL124227 Page 5 - End of Repozrt 11 ini Exhibit T 0011 FILED: NEW YORK COUNTY CLERK 05/07/2024 04:55 PM INDEX NO. 805128/2019 NYSCEF DOC. NO. 312 RECEIVED NYSCEF: 05/07/2024 PATIENT: DATE: ----------- -— REASON FOR VISIT; RE: £ MEDICATIONS; ...............- -■RECOMMENDATIONS: ■6-at REFERRALS; .. ;- ---------------------------------------------------- - , ■„ , 'V'^l DX 1.,2.I 3. 4.: F/L SIGNATURE: 12 Exhibit T 0012 FILED: NEW YORK COUNTY CLERK 05/07/2024 04:55 PM INDEX NO. 805128/2019 NYSCEF DOC. NO. 312 RECEIVED NYSCEF: 05/07/2024 PAtlEfJT SERVitE ORPfeR F&RM TODAY'S DATE H/ | I *^1 DR, KRUMHOLZ . DR. ROONEY PATIENT DATE OF BIRTH . . . ADDRESS ___________________________ __________________ =____________ SS#„. ... INSURANCE^ID# ________________ CO-PAY $ • ORDERS FOR OyTSIPE SERVICES 0 CHEST X-RAY UA SONOGRAM:______________________________________ D STRESS TEST UC CT SCAN:___________________________________ _ HEMOCULT D BE D MRI: - ■_______________________________ STOOLS D MAMMO(3fiSM RUtEaut: ... , ■BLOODS: ROUTINE_____ AMYLASE LIPASE_____ ESR_____ CELIAC Ab___ IBP MARKERS___ __ H. PYLORl__^ HEPA,B,&CAbs_____ CRP TSH,T3J4_____ IRON/TIBC_______ FERRITIN_____ LIVER PANEL,,____ • AMYLASE ISOENZYM-ES- PSA_____ PREGNANCY_____ B12______ FOLATE . OTHER ■- • . . • ................... . . : - ....................... . REFERRALS TO SPECIALISTS ALLERGY:U CARDIOLOGY: . .. . D DERMATOLOGY: _______________ ENDOCRINOLOGY: . . • . ....... Q ENT;____________________ .______________ D GASTROENTEROLOGY: , Q HEMATOLOGY:. ... ■. - . INFECTIOUS DISEASE: D NEPHROLOGY: . . . ■■NEUROLOGY:.. . 0 NUTRITION: ;__________________________ 0 - .... .. . 0 OPTHALMOLOGY: '. -_______________________ L-. ORtHUl^BblC; - ■., -....- PODIATRY: . ■■• ■. . . iJPUtNiSNARV:. ______ ____ -.... . . - D PSYCHIATRY: _______________ ____________ tiUHology:, .... . ■■■■■.- PATIENT RECALL 0 COLON OFFICE 0 HOSPITAL WHEN? 0 E6D OFFICE HOSPITAL WHEN? SIG OFFICE HOSPITAL when? Q CE WHEN?______ Q OV WHEN? . 13 Exhibit T 0013 FILED: NEW YORK COUNTY CLERK 05/07/2024 04:55 PM INDEX NO. 805128/2019 NYSCEF DOC. NO. 312 RECEIVED NYSCEF: 05/07/2024 Quest Diagnostics XBPOBT STATUS FINAL PATIENT INFORMATION MATTHEWS , REGINA QUBST DIAONOaTICS INCORPOllATBb ORDBAENO PHYSICIAN CLZEWT 3B11VZC8 B66.6S7.B37B DOB: /1972 AGE: 42 GENDER; F SPGCZKBB INPOBMMIQII CLZetTT UfFOBMATZCBI SSSCIMZN: A2r216577 T67681 10103225 REQUISITION: PHONE: ELLEN ROONEY, M.D. I-II e. both st NEW YORE, NY 1D02B COLLECTED: 04/16/2014 NONE RECEIVED: 04/17/2014 03:59 REPORTED: 04/22/2014 06:45 Test Nane In Range Out of Range Reference Range Lab LIVER PANEL II TBR PROTEIN, TOTAL, SERUM 7.4 6.1-B.l g/dL ALBUMIN 4.2 3.6-5.1 g/dL GLOBULIN, CALCULATED 3.2 1.9-3.7 g/dL BILIRUBIN, TOTAL 0.3 0.2-1.2 rog/dL BILIRUBIN, DIRECT < = 0.2 Tng/dL ALKALINE PHOSPHATASE 33-115 U/L AST 10-30 O/L ALT 6-29 U/L LD 100-200 U/L HEREDITARY HEMOCHROMAT,NY AMD DNA MUTATION ANALYSIS DNA MUTATION ANALYSIS RESUL-^^NEGATIVE INTERPRE^STIC®7^m^ testing indicates that this 41^14 individual is negative for the C2B2Y and H63D mutations in the HFE gene. This negative result significantly ■pt OjuJU/MJi-te reduces the likelihood of hereditary hemochromatosiB (HH) in this individual. However, it does not rule out the presence of other mutations within the HFE gene or a diagnosis of HH. The risk of this individual carrying a HFE mutation other than those tested in this assay depends greatly on family and clinical history as well as ethnicity. This assay does not test for other primary or secondary iron overload disorders. Kasina than Mural idharan, Ph. D., Director, Molecular Genetics Hereditary hemochromatosis (HH) is an autosomal recessive disorder of iron metabolism that results in iron overload and potential organ failure. It is one of the most comnon genetic disorders in individuals of European-Caucasian ancestry, with an estimated carrier frequency of 10%r. HH is caused by mutations in the HFE MATTHEWS,REGINA - AN216577 Page 1 - Continued on Page 2 14 ft ci ••*** *1 r W* *r >*♦••**• •av* ** IMMN*W** •v ***« Exhibit T 0014 FILED: NEW YORK COUNTY CLERK 05/07/2024 04:55 PM INDEX NO. 805128/2019 NYSCEF DOC. NO. 312 RECEIVED NYSCEF: 05/07/2024 PATIENT INFORMATION EEFORT STATOe FINAL - MATTHEWS, REGINA Q065T DZAONOSnCS IWCORPORATZD ORDERING PHYSICIAN DOB: /1972 AGE: 42 GENDER: F SPECIMEN INPOBMATiaN CLIENT INFORMATION SPECZMENt AN216577 T676B1 10103225 COLLECTED: 04'/16/2014 NOME REPOETEDi 04/22/2014 , 06:45 Teat Maz&e Zn Range Out o£ Range Reference Range Lab gene. Moat individuals with HH (60-*90%) are homozygous for the C2B2y mutation. A smaller percentage o£ affected individuals are either compound heterozygous for the C2B2Y and H63D mutations (3%~B*} , or homozygous for the H63D mutation (approximately 1%) . This assay detects the two mutations in the HFE gene, C282Y (MM_000410.2: c.B45G>A) and H63D (NM_000410.2: c. 187C>G), that are conROonly associated with HH. The mutations are detected by multiplex-polymerase chain reaction (PCR) amplification, followed by digestion of the an^lification products with the restriction enzymes Raal and NlalXI, for the detection of the C2B2Y and K63D mutations respectively. Fluorescent-labeled restriction fragments are detected by capillary electrophoresis. Thia assay does not detect other mutations in the HFE gene that can cause UH. since genetic variation and other factors can affect the accuracy of direct mutation testing, these results should be interpreted in light of clinical and familial data. For assistance with interpretation of these results, please contact your local Quest Diagnostics genetic counselor or call 1-B66-GENEINFO (436-3463). This test was developed and its performance characteristics have been determined by Quest Diagnostics Nichols Institute, Chantilly, VA. Performance characteristics refer to the analytical performance of the test. For more information on this test, go to http: //education. questdiagnostics. ccNn/faq/hemochromatos MATTHEWS,REGINA - AN216577 Page 2 - Continued on Page 3 15 Exhibit T 0015 FILED: NEW YORK COUNTY CLERK 05/07/2024 04:55 PM INDEX NO. 805128/2019 NYSCEF DOC. NO. 312 RECEIVED NYSCEF: 05/07/2024 Quest Diagnostics RBPOKT STATUS FINAL PXrXBNT INFORMATION MATTHEWS,REGINA QUEST DIAGNOSTICS IHCORPOHATBD ORDENlira mYSXCZAH DOB: /1972 AGE; 42 GENDER: F BKCIMBN ZNFORMATI(» CIjIEin ZNFORKATKNI SPECIMEN: AN216577 T67681 10103225 COLLECTED: 04716/2014 . NONE REPORTED: 04/22/2014 , 06:45 PERFORMING LABORATORY INFORMATION: AMD Quest Oiagnostics Nichols Chantilly 14225 Nevrtnrook Drive Chantilly VA 20151 Laboratory Directan Kenneth Sisco, MD,PhD CLIA No: 49DD221801 TBR Quest Diagnostics One Malcolm Avenue Teterboro NU 07608 Laboratory Director: Janet Piecitelll, H.D. CLZA No: 3100696246 MATTHEWS,REGINA - AN216S77 Page 3 - End of Report 16 Exhibit T 0016 FILED: NEW YORK COUNTY CLERK 05/07/2024 04:55 PM INDEX NO. 805128/2019 NYSCEF DOC. NO. 312 RECEIVED NYSCEF: 05/07/2024 CHP 5/24/2014 11:46:40 AM PAGE 2/003 Fax Server WEST SIDE RADlOinGY ASSOCIATES. EC. ■425 West 59th Street ♦ NEW YORK, NY 10019 ♦ Phone: (212) 523-7533 Fax: (212) 523-7318 Patient Name: MATTHEWS, REGINA ELLEN ROONEY, MD Patient Number: 10'iOOQi0^886 INTERNAL MEDICINE Date of Birth: 197?“^ 111 BAST80THST Req Provider: ROONEY, ELLEN, MD NEW YORK, NY 1002 L Att Provider: ROONEY, ELLEN Primary Study: 8355113 (5/24/14) - (WS) US UPPER ABDOMEN COMPLETE _______________________________________ FINAL REPORT___________ Dear Dr. Rooney: ULTRASOUND EXAMINATION OF THE ABDOMEN HISTOrI: Elevated LFTs FINDINGS: Ultrasound examination of the abdomen was performed. The right kidney measures approximately 10.6 cm long and the left approximately 11.1 cm long. Both kidneys demonstrate grossly normal cortical echogenicity with no evidence of hydronephrosis. The renal cortical thickness qipears well nmintained. There b no perinephric fluid collection or gross evidence of large shadowing renal stone. The liver aj^ears ncxmal in size with nonnal overall echotexture. No gross large hepatic mass is identified. There is no ascites. There is no morphologic evidmce of advanced cirrhosis. No significant intrahepatic txle duct dilatation is identified. The common duct measures approximately 2 mm, within normal limits. The spleen measures approximately 8.8 cm. There is no evidence of gallstones. No sonographic evidence of cholecystitis is noted. The partially visualized pancreas and aorta/TVC a